Evidence map›Paper›PMID 39666375›Full record

ArticleJournal of medical Internet research2024

Discussions of Cannabis Over Patient Portal Secure Messaging: Content Analysis.

Vishal A Shetty, Christina M Gregor, Lorraine D Tusing, Apoorva M Pradhan, Katrina M Romagnoli, Brian J Piper, Eric A Wright

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vishal A ShettyCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0009-0005-8016-0585
Christina M GregorCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0009-0002-0141-7441
Lorraine D TusingCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0000-0002-9091-8178
Apoorva M PradhanCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0000-0002-1066-4973
Katrina M RomagnoliCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0000-0001-8473-2126
Brian J PiperCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0000-0002-2295-445X
Eric A WrightCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, United States.ORCID 0000-0003-1721-4104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient portal secure messaging allows patients to describe health-related behaviors in ways that may not be sufficiently captured in standard electronic health record (EHR) documentation, but little is known about how cannabis is discussed on this platform.

objectiveThis study aimed to identify patient and provider secure messages that discussed cannabis and contextualize these discussions over periods before and after its legalization for medical purposes in Pennsylvania.

methodsWe examined 382,982 secure messages sent by 15,340 patients and 6101 providers from an integrated health delivery system in Pennsylvania, United States, from January 2012 to June 2022. We used an unsupervised natural language processing approach to construct a lexicon that identified messages explicitly discussing cannabis. We then conducted a qualitative content analysis on a random sample of identified messages to understand the medical reasons behind patients' use, the primary purposes of the cannabis-related discussions, and changes in these purposes over time.

resultsWe identified 1782 messages sent by 1098 patients (7.2% of total patients in the study) and 800 messages sent by 430 providers (7% of total providers in the study) as explicitly discussing cannabis. The most common medical reasons for use stated by patients in 190 sampled messages included pain or a pain-related condition (50.5% of messages), anxiety (13.7% of messages), and sleep (11.1% of messages). We coded 56 different purposes behind the mentions of cannabis in patient messages and 33 purposes in 100 sampled provider messages. In years before the legalization (2012-2016), patient and provider messages (n=20 for both) were primarily driven by discussions about cannabis screening results (38.9% and 76.5% of messages, respectively). In the years following legalization (2017-2022), patient messages (n=170) primarily involved seeking assistance to facilitate medical use (35.2% of messages) and reporting current use (25.3% of messages). Provider messages (n=80) were driven by giving assistance with medical marijuana access (27.5% of messages) and stating that they were unable to refer, prescribe or recommend medical marijuana (26.3% of messages).

conclusionsPatients showed a willingness to discuss cannabis use over patient portal secure messages and expressed interest in use after the legalization of medical marijuana. Some providers responded to patient inquiries with assistance in obtaining access to medical marijuana, while others cautioned patients on the risks of use. Insight into cannabis-related discussions through secure messages can help health systems determine opportunities to improve care processes around patients' cannabis use, and providers should be supported to communicate accurate and consistent information.

Indexed as

Patient PortalsAdultCannabisElectronic Health RecordsFemaleHumansMaleMedical MarijuanaMiddle AgedPennsylvaniaMedical Marijuanaanxietycannabiscontent analysisdepressionEHRelectronic health recordelectronic messaginginsomniamarijuanamessage contentpainpatient portalpatient-provider communicationsecure messageUnited States

Identifiers

PMID39666375
PMCPMC11671783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.